You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 10,093,654


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,093,654 protect, and when does it expire?

Patent 10,093,654 protects IDHIFA and is included in one NDA.

This patent has forty-one patent family members in twenty-four countries.

Summary for Patent: 10,093,654
Title:Therapeutically active compounds and their methods of use
Abstract: Provided are compounds useful for treating cancer and methods of treating cancer, comprising administering to a subject in need thereof a compound described herein.
Inventor(s): Agresta; Samuel V. (Lexington, MA), Gu; Chong-Hui (Waban, MA), Schenkein; David (Boston, MA), Yang; Hua (Acton, MA), Guo; Liting (Suzhou, CN), Tang; Zhen (Suzhou, CN), Wang; Jianming (Suzhou, CN), Zhang; Yanfeng (Suzhou, CN), Zhou; Yan (Suzhou, CN)
Assignee: Agios Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/649,551
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,093,654

Introduction to Patents and Patent Scope

A patent is a property right granted to an inventor by the U.S. government, allowing the inventor to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States[5].

Overview of United States Patent 10,093,654

United States Patent 10,093,654, titled "Therapeutically active compounds and their methods of use," discloses methods for treating advanced hematologic malignancies such as acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS)[4].

Patent Claims: The Heart of Patent Protection

Importance of Claims

The claims in a patent application are crucial as they define the scope of the patent's protection. These claims must be clear, concise, and fully supported by the specification and drawings included in the patent application[5].

Claims in US Patent 10,093,654

The patent claims in US 10,093,654 are focused on specific therapeutically active compounds and their methods of use. Here are some key aspects:

  • Compound Definitions: The patent describes various forms of a compound, such as Form 10, Form 11, Form 12, and Form 13 of compound 1. Each form is detailed in the examples section and represented by data shown in figures[4].
  • Methods of Use: The claims include methods for treating hematologic malignancies using these compounds. This involves specific dosages, administration routes, and therapeutic regimens.
  • Novelty and Non-obviousness: The claims must meet the criteria of being novel, non-obvious, and useful, as defined by U.S. patent laws[5].

Patent Scope and Its Measurement

Metrics for Measuring Patent Scope

Patent scope can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims[3].

Application to US Patent 10,093,654

  • Claim Length and Count: The patent's claims would be analyzed for their length and count to determine the scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[3].
  • Breadth of Protection: The scope of the patent would be evaluated based on the breadth of the claims, ensuring they are not overly broad or vague, which could lead to licensing and litigation issues.

Patent Landscape and Technology Areas

Classification and Technology Areas

Patents are classified into various technology areas to analyze trends and focus areas. The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 International Patent Classification (IPC) technical fields[1].

Relevance to US Patent 10,093,654

  • Chemical and Pharmaceutical Patents: This patent falls under the chemistry and pharmaceutical technology areas. The increase in patents in these fields reflects the growing focus on medical and therapeutic innovations.
  • Global Trends: The patent landscape in the U.S. and globally shows a significant rise in patents related to health sciences and biotechnology, indicating a strong research and development focus in these areas[1].

Patent Application and Prosecution Process

Filing and Prosecution

The patent application process involves filing a non-provisional or provisional application, followed by a review by a patent examiner. The examiner checks for compliance with legal requirements, conducts a prior art search, and determines if the claimed invention is useful, novel, and non-obvious[5].

Application to US Patent 10,093,654

  • Filing Type: The patent was likely filed as a non-provisional utility patent application, given its detailed specification and claims.
  • Examination Process: The patent examiner would have reviewed the application, including the claims, to ensure they meet the statutory requirements. Any rejections or objections would have been addressed through Office Actions and subsequent responses from the applicant or their attorney.

Key Takeaways

  • Claims Define Scope: The claims in US Patent 10,093,654 are critical in defining the scope of protection for the therapeutically active compounds and their methods of use.
  • Metrics for Scope: Metrics such as claim length and count can help assess the breadth and clarity of the patent claims.
  • Technology Area: The patent falls under the chemistry and pharmaceutical technology areas, reflecting the growing focus on medical innovations.
  • Application and Prosecution: The patent went through a rigorous application and examination process to ensure it meets the legal requirements for patentability.

FAQs

What is the primary focus of US Patent 10,093,654?

The primary focus of US Patent 10,093,654 is on therapeutically active compounds and their methods of use for treating advanced hematologic malignancies.

How are patent claims measured for scope?

Patent claims can be measured for scope using metrics such as independent claim length and independent claim count.

What technology area does US Patent 10,093,654 fall under?

US Patent 10,093,654 falls under the chemistry and pharmaceutical technology areas.

What is the significance of the USPTO's classification system?

The USPTO's classification system, based on WIPO's 35 IPC technical fields, helps in analyzing trends and focus areas in patent filings.

Why are prior art searches important in the patent application process?

Prior art searches are crucial to determine if the invention has been previously disclosed, ensuring that the invention is novel and non-obvious.

Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Therapeutically active compounds and their methods of use - Google Patents
  5. Patents | The Maryland People's Law Library

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,093,654

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bristol Myers Squibb IDHIFA enasidenib mesylate TABLET;ORAL 209606-001 Aug 1, 2017 RX Yes No 10,093,654 ⤷  Subscribe Y Y TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH AN ISOCITRATE DEHYDROGENASE-2 (IDH2) MUTATION ⤷  Subscribe
Bristol Myers Squibb IDHIFA enasidenib mesylate TABLET;ORAL 209606-002 Aug 1, 2017 RX Yes Yes 10,093,654 ⤷  Subscribe Y Y TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH AN ISOCITRATE DEHYDROGENASE-2 (IDH2) MUTATION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,093,654

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
PCT/CN2013/081170Aug 9, 2013

International Family Members for US Patent 10,093,654

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 097237 ⤷  Subscribe
Australia 2014295938 ⤷  Subscribe
Australia 2018247242 ⤷  Subscribe
Brazil 112016002287 ⤷  Subscribe
Canada 2919382 ⤷  Subscribe
Chile 2016000263 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.